Polymorphic Variations Associated With Doxorubicin-Induced Cardiotoxicity in Breast Cancer Patients

Doxorubicin (DOX) is a commonly used antineoplastic agent for the treatment of various malignancies, and its use is associated with unpredictable cardiotoxicity. Susceptibility to DOX cardiotoxicity is largely patient dependent, suggesting genetic predisposition. We have previously found that indivi...

Descripción completa

Detalles Bibliográficos
Autores principales: Todorova, Valentina K., Makhoul, Issam, Dhakal, Ishwori, Wei, Jeanne, Stone, Annjanette, Carter, Weleetka, Owen, Aaron, Klimberg, V. Suzanne
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Cognizant Communication Corporation 2017
Materias:
Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7841056/
https://www.ncbi.nlm.nih.gov/pubmed/28256194
http://dx.doi.org/10.3727/096504017X14876245096439

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7841056/
https://www.ncbi.nlm.nih.gov/pubmed/28256194
http://dx.doi.org/10.3727/096504017X14876245096439

Ejemplares similares